Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
hGH-CTP (MOD-4023)
print preview
bookmark
share with colleague
General Information
Company
Prolor Biotech Inc.
Description
Long-acting human growth hormone (hGH) combined with the company's carboxyl terminal peptide (CTP) technology
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase II
Indication
Growth hormone deficiency
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy